3D bioprinting directly into injured sites in a surgical setting, intraoperative bioprinting (IOB), is an effective process, in which the defect information can be rapidly acquired and then repaired via bioprinting on a live subject. In patients needing tissue resection, debridement, traumatic reconstruction, or fracture repair, the ability to scan and bioprint immediately following surgical preparation of the defect site has great potential to improve the precision and efficiency of these procedures. In this opinion article, we provide the reader with current major limitations of IOB from engineering and clinical points of view, as well as possibilities of future translation of bioprinting technologies from bench to bedside, and expound our perspectives in the context of IOB of composite and vascularized tissues.

Original languageEnglish (US)
Pages (from-to)594-605
Number of pages12
JournalTrends in Biotechnology
Issue number6
StatePublished - Jun 2020

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering


Dive into the research topics of 'Intraoperative Bioprinting: Repairing Tissues and Organs in a Surgical Setting'. Together they form a unique fingerprint.

Cite this